Results 241 to 250 of about 127,473 (295)

Long-Term Health Outcomes of Huntington Disease and the Impact of Future Disease-Modifying Treatments: A Decision-Modeling Analysis. [PDF]

Neurol Clin Pract
Guzauskas GF, Tabrizi SJ, Long JD, Arnesen A, Hamilton JL, Claassen DO, Munetsi LR, Malik S, Rodríguez-Santana I, Ali TM, Zhang F.   +10 more
europepmc   +1 more source

Huntington disease alters the actionable information in plasma extracellular vesicles. [PDF]

Clin Transl Med
Neueder A, Nitzschner P, Wagner R, Hummel J, Hoschek F, Wagner M, Abdelmoez A, von Einem B, Landwehrmeyer GB, Tabrizi SJ, Orth M.   +10 more
europepmc   +1 more source

Dark Adaptometry and Optical Coherence Tomography Angiography in Huntington Disease. [PDF]

J Ophthalmic Vis Res
Shah A, Fuller S, Criswell S, Apte RS.
europepmc   +1 more source

Therapeutic validation of MMR-associated genetic modifiers in a human ex vivo model of Huntington disease. [PDF]

Am J Hum Genet
Ferguson R, Goold R, Coupland L, Flower M, Tabrizi SJ.   +4 more
europepmc   +1 more source

Huntington's Disease‐like Syndrome as a Rare Presentation of CACNA1A‐Related Disorder

Movement Disorders Clinical Practice, Volume 13, Issue 5, Page 1322-1325, May 2026.
Petros Boumis, Constantin Potagas, Christos Koros, Vasilios Constantinides, Nikolaos Ragazos, Chrysoula Koniari, Stavroula Aristeidou, Chrisoula Kartanou, Emmanouela Linardaki, Nektarios Tavernarakis, Evangelos Anagnostou, Leonidas Stefanis, Socratis Papageorgiou, Georgia Karadima, Georgios Koutsis   +14 more
wiley   +1 more source

Validation of the German Version of the Movement Disorder Society Non‐Motor Scale (MDS‐NMS)

Movement Disorders Clinical Practice, Volume 13, Issue 5, Page 1346-1348, May 2026.
Jonas Bendig, Anika Frank, Adrianna Lipska‐Dieck, Kristof Wunderlich, David Geißler‐Lösch, Isabel Wurster, Roswitha Kemmner, Kathrin Brockmann, Sheng Luo, Christopher G. Goetz, Glenn T. Stebbins, Pablo Martinez‐Martin, Tiago A. Mestre, Alvaro Sanchez‐Ferro, Monica M. Kurtis, Michelle H.S. Tosin, Roberta Balestrino, Chi‐Ying R. Lin, Carmen Gasca‐Salas, Heinz Reichmann, Bjoern H. Falkenburger   +20 more
wiley   +1 more source

Huntington disease [PDF]

Nature Reviews Disease Primers, 2015
Huntington disease is devastating to patients and their families - with autosomal dominant inheritance, onset typically in the prime of adult life, progressive course, and a combination of motor, cognitive and behavioural features. The disease is caused by an expanded CAG trinucleotide repeat (of variable length) in HTT, the gene that encodes the ...
Gillian P Bates, James F Gusella, Michael R Hayden   +2 more
exaly   +9 more sources

Some of the next articles are maybe not open access.

Related searches:

Huntington’s Disease

BMJ, 2010
Huntington's disease (HD) is one of the most frequently found neurodegenerative disorders. Its main clinical manifestations are chorea, cognitive impairment and psychiatric disorders. It is an autosomal-dominant disorder with almost complete penetrance.
Emmanuel, Roze, Cecilia, Bonnet, Sandrine, Betuing, Jocelyne, Caboche   +3 more
  +9 more sources